Intravitreal aflibercept compared with panretinal photocoagulation for proliferative diabetic retinopathy: the CLARITY non-inferiority RCT
Background: Panretinal photocoagulation (PRP) has been the standard of care for patients with proliferative diabetic retinopathy (PDR) for the last 40 years. It prevents severe visual loss in PDR but is also associated with adverse effects on visual functions. Objectives: The clinical efficacy and m...
Main Authors: | Sobha Sivaprasad, Philip Hykin, A Toby Prevost, Joana Vasconcelos, Amy Riddell, Jayashree Ramu, Caroline Murphy, Joanna Kelly, Rhiannon Tudor Edwards, Seow Tien Yeo, James Bainbridge, David Hopkins, Beverley White-Alao |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2018-10-01
|
Series: | Efficacy and Mechanism Evaluation |
Subjects: | |
Online Access: | https://doi.org/10.3310/eme05050 |
Similar Items
-
Bilateral Hypertensive Retinopathy Complicated with Retinal Neovascularization: Panretinal Photocoagulation or Intravitreal Anti-VEGF Treatment
by: Odysseas Georgiadis, et al.
Published: (2014-07-01) -
A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy
by: Yaoyao Sun, et al.
Published: (2023-01-01) -
Sub-panretinal photocoagulation <i>vs</i> panretinal photocoagulation for pre-proliferative diabetic retinopathy: a prospective non-randomized study
by: Li Wang, et al.
Published: (2016-03-01) -
Panretinal Photocoagulation: A Teaching Module
by: G. Atma Vemulakonda
Published: (2013-10-01) -
Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study
by: Wei Zhang, et al.
Published: (2021-04-01)